SCHEMBL7323586

SCHEMBL7323586

O=c1c(-c2cccs2)noc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
CASP1 P29466 3/20 0.51
CASP7 P55210 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
USP2 O75604 1/20 0.51
GAA P10253 1/20 0.51
TSHR P16473 1/20 0.51
MAPK1 P28482 1/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 8/20 0.42
HPGD P15428 4/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
F2 P00734 1/20 0.42
PLK1 P53350 1/20 0.42
ADORA2A P29274 2/20 0.41
MAOB P27338 1/20 0.40
ESR1 P03372 1/20 0.40
ESR2 Q92731 1/20 0.40
GLA P06280 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5202274 0.76 ESR1 (0.50) KDM4ECASP1CASP7ALDH1A1HPGD
SCHEMBL16927398 0.75 NR4A2 (0.46) KDM4ECASP1CASP7MEN1KMT2A
SCHEMBL11553711 0.71 PLK1 (0.44) KDM4EMEN1KMT2ATSHRHTT
SCHEMBL312058 0.70 ESR1 (0.57) KDM4EMEN1KMT2AUSP2GAA
SCHEMBL29549526 0.70 KDM4E (0.52) KDM4ECASP1CASP7MEN1KMT2A
SCHEMBL5246464 0.68 KDM4E (1.00) KDM4ECASP1CASP7MEN1KMT2A
SCHEMBL28256199 0.68 MEN1 (0.69) KDM4ECASP1CASP7MEN1KMT2A
SCHEMBL28257700 0.68 MEN1 (0.69) KDM4ECASP1CASP7MEN1KMT2A
SCHEMBL6439681 0.67 MAOA (0.48) KDM4ECASP1CASP7GAAALDH1A1
SCHEMBL29940757 0.67 KDM4E (0.48) KDM4ECASP1CASP7GAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6180625-B1 MODULATING AND NORMALIZING AN IMPAIRED HAEMOSTATIC BALANCE IN A MAMMAL, WHICH METHOD COMPRISES ADMINISTERING AN EFFECTIVE AMOUNT OF NOVEL BENZOXAZIN DERIVATIVES; ANTICOAGULANTS NOVO NORDISK A/S (DK) 2001-01-30 US disclosed
WO-1999048878-A1 HETEROCYCLIC COMPOUNDS REGULATING CLOTTING NOVO NORDISK A/S (DK) 1999-09-30 WO disclosed